Active Versus Passive Anal Sphincter Training in Patients With Fecal Incontinence
ACTIPAST
1 other identifier
interventional
24
1 country
1
Brief Summary
Fecal incontinence is a disabling condition that can substantially impair quality of life. This study evaluates whether home-based anal electrical stimulation combined with active voluntary anal sphincter contraction is superior to electrical stimulation alone in patients with fecal incontinence. The study is a prospective, randomized, parallel-group, open-label controlled trial. Participants will be randomized in a 1:1 ratio to either electrical stimulation with synchronized active sphincter contraction or electrical stimulation alone. The primary outcome is the change in Vaizey/St. Mark's Incontinence Score from baseline to week 12. Secondary outcomes include fecal incontinence episodes, quality of life, anorectal manometry parameters, adherence, safety, and sustained response during follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 15, 2026
CompletedFirst Submitted
Initial submission to the registry
May 17, 2026
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2029
May 22, 2026
May 1, 2026
3 years
May 17, 2026
May 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Vaizey (St. Mark's) Incontinence Score From Baseline to Week 12
Mean change in Vaizey (St. Mark's) Incontinence Score between baseline and week 12. The Vaizey score ranges from 0 to 24, with higher scores indicating more severe fecal incontinence symptoms.
Baseline to Week 12
Secondary Outcomes (9)
Change in Weekly Fecal Incontinence Episodes From Baseline to Week 12
Baseline to Week 12
Proportion of Participants Achieving ≥30% Reduction in Vaizey Score at Week 12
Week 12
Sustained Improvement in Vaizey Score at Week 36
Baseline to Week 36
Change in Maximum Squeeze Pressure on High-Resolution Anorectal Manometry
Baseline to Week 12
Change in Resting Anal Pressure on High-Resolution Anorectal Manometry
Baseline to Week 12
- +4 more secondary outcomes
Study Arms (2)
Electrical Stimulation + Active Contraction
ACTIVE COMPARATORHome-based anal electrical stimulation combined with synchronized active voluntary anal sphincter contraction for 12 weeks
Electrical Stimulation Alone
ACTIVE COMPARATORHome-based anal electrical stimulation alone without active voluntary sphincter contraction for 12 weeks.
Interventions
Home-based anal electrical stimulation delivered using the NeuroTrac Continence device. Stimulation parameters include frequency 40 Hz, pulse width 250 µs, 5 seconds ON and 10 seconds OFF cycles, 1-second ramp-up, session duration 25 minutes, and patient-adjusted intensity up to the maximum tolerable level without pain.
Eligibility Criteria
You may qualify if:
- Signed informed consent
- Age ≥18 years
- Diagnosis of fecal incontinence (urge, passive, or mixed type) with at least 1 episode of involuntary stool leakage requiring hygiene intervention or underwear change per month for ≥3 months
- Vaizey (St. Mark's) Incontinence Score ≥8
- Ability to understand study procedures and comply with the 12-week home intervention
- Willingness to attend all study visits and assessments
- Stable medical management for fecal incontinence for at least 4 weeks prior to enrollment
You may not qualify if:
- Complete spinal cord injury above the conus medullaris
- Active inflammatory bowel disease flare requiring systemic therapy or not in clinical remission
- Rectal prolapse requiring surgical intervention
- Severe symptomatic hemorrhoids interfering with anorectal assessments or device use
- Active anal fissure or perianal fistula
- Active colorectal cancer or history of colorectal cancer within 5 years
- Colorectal surgery within the previous 6 months
- Pregnancy or planned pregnancy during study participation
- Implanted cardiac pacemaker or defibrillator
- Other implanted electrical devices contraindicating electrical stimulation
- Previous specialized pelvic floor physiotherapy, biofeedback therapy, EMG-guided rehabilitation, or anal electrical stimulation within 3 months prior to randomization
- Cognitive impairment preventing understanding of study procedures or informed consent
- Uncontrolled severe diarrhea (\>5 liquid stools/day)
- Anal stenosis preventing probe insertion
- Severe anal sphincter defect (\>120° on ultrasound) requiring surgical repair
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Martinlead
- Comenius Universitycollaborator
Study Sites (1)
Clinic of Internal Medicine- Gastroenterology, University Hospital Martin
Martin, 03601, Slovakia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Peter Liptak, MD, PhD
Clinic of Internal Medicine- Gastroenterology, University Hospital Martin, Jessenous Faculty of Medicine in Martin, Comenius University, Slovakia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the intervention, neither participants nor investigators can be blinded. Participants are aware whether they perform active voluntary sphincter contractions during stimulation, and investigators are involved in patient training and outcome assessments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Gastroenterologist and clinical researcher
Study Record Dates
First Submitted
May 17, 2026
First Posted
May 22, 2026
Study Start
May 15, 2026
Primary Completion (Estimated)
May 1, 2029
Study Completion (Estimated)
May 1, 2029
Last Updated
May 22, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 6 months after publication of the primary study results and ending 5 years after publication
- Access Criteria
- Access will be provided to qualified researchers whose proposed use of the data has been approved by the study investigators and relevant institutional authorities. A data access agreement may be required.
De-identified individual participant data underlying the reported study results may be shared upon reasonable request to the principal investigator following publication of the primary results. Data sharing will be considered for methodologically sound research proposals and in accordance with institutional policies, ethical approval requirements, and applicable data protection regulations (including GDPR).